Location History:
- Raritan, NJ (US) (2022)
- Blue Bell, PA (US) (2020 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: **Daniel Jason Krosky: Innovator in Pharmaceutical Development**
Introduction
Daniel Jason Krosky, based in Blue Bell, Pennsylvania, is a prominent inventor with a focus on pharmaceutical innovations. With a remarkable portfolio of 7 patents, he has made significant contributions to the field of drug development, particularly in targeting protein interactions associated with various diseases.
Latest Patents
Among his latest inventions are two significant patents that address critical health concerns. The first is a patent for **Spiro Bicyclic Inhibitors of Menin-MLL Interaction**. This invention relates to pharmaceutical agents designed for therapy and prophylaxis in mammals, specifically targeting spiro bicyclic compounds. These agents serve as inhibitors of the menin/MLL protein/protein interaction, proving useful in the treatment of diseases such as cancer, myelodysplastic syndrome (MDS), and diabetes.
The second patent is for **Azepane Inhibitors of Menin-MLL Interaction**. Similar to his previous work, this invention focuses on azepane compounds that function as inhibitors of the same protein interactions, again aimed at treating cancer, MDS, and diabetes.
Career Highlights
Daniel Jason Krosky is affiliated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role there has allowed him to leverage his expertise in developing innovative therapies that impact patient care and treatment efficacy. His contributions have not only advanced scientific knowledge but have also paved the way for new therapeutic strategies.
Collaborations
Daniel has collaborated with esteemed colleagues such as Vineet Pande and Olivier Alexis Georges Querolle. These collaborations demonstrate the importance of teamwork in scientific research and innovation, enabling the pooling of knowledge and skills to achieve remarkable advancements in drug discovery.
Conclusion
Daniel Jason Krosky exemplifies the spirit of innovation within the pharmaceutical domain. His dedication to developing effective therapeutic agents through his patented inventions underscores his commitment to improving health outcomes. As a valued member of Janssen Pharmaceutica NV, he continues to contribute significantly to the field, reinforcing the crucial role of inventors in advancing medical science.